• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Device Problem Contamination (1120)
Patient Problem Unspecified Infection (1930)
Event Date 11/24/2021
Event Type  Injury  
Manufacturer Narrative
The date of incident is unknown.Therefore, the date of which the incident was received from a third party investigator is used as date of event.The medical device returned to a third party for investigation.The analysis report was shared with gore and evaluated appropriately.
 
Event Description
It was reported to gore that a gore® excluder® aaa endoprostheses was implanted in another center in order to treat an aneurysm (date unknown).On (b)(6) 2021, the endoprosthesis was explanted due to infection.
 
Manufacturer Narrative
Explant scientist observations from the report provided by third party investigator (geprovas): the abluminal surfaces were generally devoid to tissue with minimal, scattered plaques of red/brown tissue present.A foci of tan/brown tissue was present near the distal aspect of segment 2.The luminal surfaces were generally devoid of tissue, except for minimal red/brown tissue being present.A few segments had areas of dark red tissue accumulation (presumptive sedimented blood) inside of the lumen.All the lumens were widely patent.The first segment consisted of the distal, tapered aspect of a cl.The segment was circumferentially transected at the proximal aspect.Alignment of the proximal edge could not be achieved with any other fragment with the information/images provided.Per geprovas, "some stent crowns are not structured anymore." however, no defects in the stent structure/attachment to the segment were observable by the ei.The second segment was a cl endoprosthesis.No material disruptions were identified.The segment presented with a slight, s-shaped bend.Material disruptions (i.E., transections, stent frame displacement) were consistent with those caused by interaction with surgical instrumentation (i.E., scalpel/scissors, forceps/clamps), which were likely used during the explant process.A review of the manufacturing records for the device could not be conducted because the serial/lot number remains unknown.Multiple attempts have been made to acquire additional information to classify any possible specific device problem, device identification, and event dates.No additional information has been provided.D10: concomitant medical products: gore® excluder® aaa endoprosthesis - stent graft contralateral leg endoprosthesis.Gore® excluder® iliac branch endoprosthesis - stent graft iliac branch component endoprosthesis (x3).Gore® excluder® iliac branch endoprosthesis - stent graft internal iliac component endoprosthesis.H6: added investigation conclusions codes 4315 and 22.Per gore® excluder® aaa endoprosthesis instructions for use (ifu), adverse events that may occur and/or require intervention include, but are not limited to: infection (e.G., aneurysm, device or access sites).Corrected h6: removed type of investigation code 4119 - insufficient information available.Updated investigation findings code to 213 - no device problem found.Code 3221 is no longer applicable.Removed investigation conclusions code 11 - conclusion not yet available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® EXCLUDER® AAA ENDOPROSTHESIS
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL PHOENIX 2 B/P
32470 n. north valley parkway
phoenix AZ 85085
Manufacturer Contact
ida simson
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key12961324
MDR Text Key281926504
Report Number3007284313-2021-01695
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
P020004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/03/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/24/2021
Initial Date FDA Received12/08/2021
Supplement Dates Manufacturer Received02/03/2022
Supplement Dates FDA Received03/03/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
SEE H10
Patient Outcome(s) Other;
Patient Age74 YR
Patient SexMale
-
-